11. Antithrombotic therapies

Six versus twelve months DAPT after DES for STEMI

DAPT-STEMI
Objective
to compare six months DAPT versus 12 months DAPT
Study
multicentre, open-label, non-inferiority randomised controlled trial
Population
patients treated with zoterolimus eluting stents for STEMI + event free at 6 months
Endpoints
death, any myocardial infarction, any revascularisation, stroke, major bleeding at 2 years
Conclusion
6 months DAPT was not inferior to 12 months DAPT
Kedhi et al. BMJ. 2018;363:k3793
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved